EMT, Stemness, and Drug Resistance in Biological Context: A 3D Tumor Tissue/In Silico Platform for Analysis of Combinatorial Treatment in NSCLC with Aggressive KRAS-Biomarker Signatures.
Peindl M, Göttlich C, Crouch S, Hoff N, Lüttgens T, Schmitt F, Pereira JGN, May C, Schliermann A, Kronenthaler C, Cheufou D, Reu-Hofer S, Rosenwald A, Weigl E, Walles T, Schüler J, Dandekar T, Nietzer S, Dandekar G.
Peindl M, et al. Among authors: nietzer s.
Cancers (Basel). 2022 Apr 27;14(9):2176. doi: 10.3390/cancers14092176.
Cancers (Basel). 2022.
PMID: 35565305
Free PMC article.